Jobs
-
On the second day of the Drug Delivery to the Lungs meeting in December 2010 (DDL 21), Xiang Kou, a grad student from the National University of Singapore who had been spending time as a… Read more . . .
-
The Impactor Sub-Team of the European Pharmaceutical Aerosol Group (EPAG), a consortium of pharmaceutical companies that develop pulmonary and intranasal drugs, has focused its attention on the potential benefits of the abbreviated impactor method (AIM),… Read more . . .
-
At the next IPAC-RS conference, March 29-31 in Rockville, MD, sponsored by the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS), OINDP specialists will have uncommon opportunities to interact with regulators, representatives of patient… Read more . . .
-
On Friday, December 10, just as the snow was beginning to melt in Edinburgh, DDL 21 concluded with one last podium session. Delegates also had a chance to spend some additional time at the exhibition.… Read more . . .
-
The second day of DDL 21 offered a wide variety of presentations, a focus on young investigators and the presentation of several awards, in addition to a continuation of the exhibition. By Day 2, most… Read more . . .
-
DDL 21 kicked off on Wednesday, December 8 with an EPAG workshop on the abbreviated impactor measurement (AIM) technique attended by 85 inhalation scientists who elected to attend the workshop in addition to the main… Read more . . .
-
Over the past few years, it has become increasingly difficult to ignore the rising cultural influence of social media. One of this year’s top movies documents the founding of Facebook; even major news outlets report… Read more . . .
-
David Cipolla, Aradigm A number of outstanding books have been written for medical practitioners who treat lung disease, including Murray and Nadel’s Textbook of Respiratory Medicine and Farzan’s Concise Handbook of Respiratory Diseases. These books… Read more . . .
-
Australian company Pharmaxis is launching its Aridol inhaled dry powder mannitol bronchial challenge test in the US. The FDA approved the product in October 2010 for the assessment of bronchial hyperresponsiveness in patients 6 years… Read more . . .
-
The Asthma and Allergy Foundation of America (AAFA) has published its annual list of US “asthma capitals,” led this year by Richmond, Virginia. The list ranks 100 metropolitan areas in terms of difficulties that they… Read more . . .
Featured event:

Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK



